These results suggest that constitutive activation of the AKT, but not mTOR or MAPK, pathways is involved in the pathogenesis of iMycEμ lymphoma, independent of loss or mutation of either Pten or Pik3ca. The gene discussed is AKT1; the disease is lymphoma.